COVID-19 vaccine hesitancy

COVID-19 vaccine hesitancy

MOD1

MOD1

T-cell development
T-cell activation
Antibody classes
Cell-mediated immunity of natural killer and CD8 cells
B- and T-cell memory
B-cell activation, differentiation, and contraction
B-cell development
Inflammation
Wound healing
VDJ rearrangement
Somatic hypermutation and affinity maturation
MHC class I and MHC class II molecules
Cell-mediated immunity of CD4 cells
Introduction to the immune system
Complement system
Metaplasia and dysplasia
Necrosis and apoptosis
Contracting the immune response and peripheral tolerance
Innate immune system
Abscesses
Hyperplasia and hypertrophy
Atrophy, aplasia, and hypoplasia
Bacterial structure and functions
Viral structure and functions
Candida
Polymerase chain reaction (PCR) and reverse-transcriptase PCR (RT-PCR)
ELISA (Enzyme-linked immunosorbent assay)
Protein synthesis inhibitors: Aminoglycosides
Antimetabolites: Sulfonamides and trimethoprim
Antituberculosis medications
Miscellaneous cell wall synthesis inhibitors
Protein synthesis inhibitors: Tetracyclines
Cell wall synthesis inhibitors: Penicillins
Miscellaneous protein synthesis inhibitors
Cell wall synthesis inhibitors: Cephalosporins
DNA synthesis inhibitors: Metronidazole
DNA synthesis inhibitors: Fluoroquinolones
Mechanisms of antibiotic resistance
Pharmacokinetics: Drug absorption and distribution
Pharmacokinetics: Drug metabolism
Pharmacokinetics: Drug elimination and clearance
COVID-19 mutant variants and herd immunity
Development of the COVID-19 vaccine
Dr. Tom Frieden: Former Director of the CDC (Raise the Line)
Incidence and prevalence
Prevention
Vaccinations: Clinical
COVID-19 vaccine hesitancy
Flatten the curve, raise the line music video
DALY and QALY
Hand hygiene (for nursing assistant training)
Types of personal protective equipment (for nursing assistant training)
Standard and transmission-based precautions (for nursing assistant training)
Type III hypersensitivity
Type IV hypersensitivity
Type I hypersensitivity
Type II hypersensitivity
Non-steroidal anti-inflammatory drugs
Lupus nephritis
IgA nephropathy (NORD)
Myasthenia gravis
Membranous nephropathy
Rheumatoid arthritis
Vasculitis
Vasculitis: Pathology review
Systemic lupus erythematosus (SLE): Clinical
Renal system anatomy and physiology
Kidney histology
Rapidly progressive glomerulonephritis
Sjogren syndrome
Graves disease
Bullous pemphigoid
Asthma
Systemic lupus erythematosus
Goodpasture syndrome
Acetaminophen (Paracetamol)
Glucocorticoids
Complement deficiency
Atopic dermatitis
Erythema multiforme
Non-corticosteroid immunosuppressants and immunotherapies
BK virus (Hemorrhagic cystitis)
Transplant rejection

Transcript

Watch video only

Content Reviewers

Contributors

Vaccine hesitancy has become a significant health concern, and is defined by the World Health Organization as “a delay in acceptance or refusal of vaccination despite availability of vaccination services”

Vaccine hesitancy is a complex issue, and its causes are unique to each individual.

While vaccine hesitancy has been an ongoing public health issue for years, the rapid development of vaccines in response to the COVID-19 pandemic has exacerbated the issue.

A survey by Fisher et al. in September 2020 revealed 11% of people in the United States plan to decline the COVID-19 vaccine, with another 32% of people undecided if they’d accept the vaccine.

With such a large percentage of the population being hesitant to vaccination, it’s imperative healthcare providers initiate and maintain an open dialog about vaccination with patients.

Patients are often willing to have a discussion about vaccination, even if they are hesitant to receive a vaccine.

When beginning a dialog on vaccines with patients, always ensure you frame the discussion in a positive, non-confrontational light.

Be respectful and truly understand the person’s perspective. Do they feel worried? Do they feel suspicious?

These are legitimate feelings that warrant a conversation about safety and the process of how vaccines get made and evaluated before they’re given to patients.

Even if the patient decides not to be vaccinated, it is important to maintain a strong healthcare provider-patient relationship so that you can continue to engage them over time.

The more opportunities you have to engage them, the more likely a skeptical patient may be to change their mind and decide to become vaccinated.

Patients are the ultimate decision makers on whether they’ll be vaccinated or not.

Your role as a healthcare provider is to be a resource to them.

Reinforcing this with the patient will help build trust and a strong clinician-patient relationship.

Highlight that both of you have shared goals, to do what is best for them, and acknowledge that there is an enormous amount of difficult to understand information around vaccines.

Let the patient know you want them to be able to make an informed decision.

Offer to help them find the best information on vaccines, and that you are available to answer any questions they might have.

As soon as possible, try to establish how knowledgeable the patient is on COVID-19 and the vaccines, as well as how strong their beliefs are regarding vaccination generally.

Knowing if a patient has strong opposition to vaccination early on will help you make decisions on how to navigate your conversation with them in order to maintain a good relationship with the patient.

Avoid making presumptuous statements, that limit what a patient can say in response, such as “Would you like me to schedule you for a COVID-19 vaccine?” or “Have you received your COVID-19 vaccine yet?”

Instead focus on more participatory dialog, and use open-ended prompts, such as “What are your thoughts on the COVID-19 vaccination rollout?” or “How do you feel about the COVID-19 vaccines?”.

Both the American Academy of Pediatrics and the World Health Organization have sample scripts healthcare providers may find helpful as they prepare to initiate dialogues with their patients.

When talking about vaccines, avoid referring to complicated statistics or using complicated terms unless the patient specifically asks for clarification.

Instead focus on the key information and broad takeaways.

You want to keep the message clear and concise to patients, but also answer specific questions they have.

When possible, personalize information to patients, explaining how information affects them specifically based on their health history.

For example, patients who are thinking about becoming pregnant, or who are currently taking immunosuppressive medications may wonder if they should take the new COVID-19 vaccines.

Contextualizing information like vaccine risks is also important.

Key Takeaways

The World Health Organization defines vaccine hesitancy as a delay in acceptance or refusal of vaccination despite the availability of vaccination services. � There is a great deal of hesitancy surrounding the potential COVID-19 vaccine. Some of this hesitancy may be due to general distrust in pharmaceutical companies, while other concerns may be specific to the vaccine.

There are concerns that the vaccine could lead to severe side effects, although these claims have not yet been substantiated. Some people also worry that the vaccine will be used for nefarious purposes, such as controlling the population or profiting from vaccine sales. Still, studies have revealed that COVID-19 vaccines have saved many lives by reducing adverse outcomes, including deaths and hospital admissions, especially in the ICU.